No significant demographic or phenotypic differences were found between HLA-DQA1*05 carriers versus non-carriers, in either treatment group.
Alex McCarthy, PharmD
Advertisement
Articles by Alex McCarthy, PharmD
Advertisement
Latest Updated Articles
HLA-DQA1*05 Genotype Does Not Influence Clinical Response to Ustekinumab, VedolizumabPublished: November 29th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Zuranolone Offers New Hope for Postpartum Depression
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Updated Hypertension Guidelines Are Here
5
